Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies.
Journal
Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
30
01
2020
revised:
16
06
2020
accepted:
30
06
2020
pubmed:
10
9
2020
medline:
30
9
2021
entrez:
9
9
2020
Statut:
ppublish
Résumé
Gastric antral vascular ectasia (GAVE) is a vascular manifestation of systemic sclerosis (SSc) that can lead to iron deficiency anemia or acute gastrointestinal (GI) bleeding. We aimed to identify clinical features associated with GAVE. We performed a cohort study of SSc patients who were seen at Stanford between 2004 and 2018 and had undergone esophagogastroduodenoscopy (EGD). We compared the clinical features of those with and without GAVE, and multivariable logistic regression was performed to identify clinical correlates with GAVE. A total of 225 patients with SSc who underwent EGD were included in this study and 19 (8.4%) had GAVE. Those with GAVE were more likely to have scleroderma renal crisis (SRC) (21% vs 3%; p < 0.01), positive anti-RNA polymerase III antibody (71% vs 19%; p < 0.01), nucleolar pattern of anti-nuclear antibody (ANA) (33% vs 11%; p=0.04), and negative ANA (<1:80 by immunofluorescence) (33% vs 11%; p=0.02). On multivariate analysis with multiple imputation, anti-RNA polymerase III positivity (OR 4.57; 95% CI (1.57 - 13.23), p < 0.01) and ANA negativity (OR 3.75; 95% CI (1.21 - 11.62), p=0.02) remained significantly associated with GAVE. Positive anti-RNA polymerase III antibody and ANA negativity were significantly associated with GAVE. Further studies are necessary to determine whether patients with these autoantibody profiles should undergo screening endoscopies for GAVE.
Identifiants
pubmed: 32906028
pii: S0049-0172(20)30195-5
doi: 10.1016/j.semarthrit.2020.06.016
pmc: PMC7584748
mid: NIHMS1628554
pii:
doi:
Substances chimiques
Antibodies, Antinuclear
0
RNA Polymerase III
EC 2.7.7.6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
938-942Subventions
Organisme : NIAMS NIH HHS
ID : T32 AR007258
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR050942
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Aliment Pharmacol Ther. 2008 Aug 15;28(4):412-21
pubmed: 18498445
J Rheumatol. 2010 Jul;37(7):1544
pubmed: 20595295
J Rheumatol. 2017 Apr;44(4):459-465
pubmed: 28089974
J Rheumatol. 2013 Apr;40(4):455-60
pubmed: 23418384
Intern Med. 2019 Jan 1;58(1):135-139
pubmed: 30101944
J Rheumatol. 2007 Nov;34(11):2230-5
pubmed: 17937469
J Rheumatol. 2014 Jan;41(1):99-105
pubmed: 24293584
Int J Rheumatol. 2015;2015:762546
pubmed: 26633973
J Rheumatol. 2010 Jan;37(1):125-30
pubmed: 19918031
Int J Rheumatol. 2011;2011:305238
pubmed: 22121374
Intern Med J. 2015 Oct;45(10):1077-81
pubmed: 26429218
Autoimmun Rev. 2009 Jun;8(7):580-4
pubmed: 19393210
Gut. 1999 May;44(5):739-42
pubmed: 10205216
J Rheumatol. 2010 Mar;37(3):603-7
pubmed: 20080908